Skip to main content
Signal8

Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC is an Investment Adviser institutional filer with the SEC under CIK 1777015, reporting 76 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Parkman Healthcare Partners LLC's most recent 13F filing, ranked by reported market value.

  1. MBX BIOSCIENCES INC (MBX)
  2. ELI LILLY & CO (LLY)
  3. CVS HEALTH CORP (CVS)
  4. DEXCOM INC (DXCM)
  5. PTC THERAPEUTICS INC (PTCT)
  6. ARCUS BIOSCIENCES INC (RCUS)
  7. STRUCTURE THERAPEUTICS INC (GPCR)
  8. VIRIDIAN THERAPEUTICS INC (VRDN)
  9. AGIOS PHARMACEUTICALS INC (AGIO)
  10. INHIBRX BIOSCIENCES INC (INBX)
/